Sun BioPharma, Inc. Provides Business Update and Reports Q2 2020 Financial Results

NEXT STORY
Myovant Sciences Announces Corporate Updates and Financial Results for First Quarter Fiscal Year 2020
PREV STORY
Arcturus Therapeutics Announces that it has Initiated Dosing of its COVID-19 STARR™ mRNA Vaccine Candidate, LUNAR-COV19 (ARCT-021) in a Phase 1/2 study
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BioNTech Plans to Initiate the Construction of an mRNA Vaccine Manufacturing Facility in Africa in mid-2022

author_avatar
NASDAQ Market News

Relay Therapeutics Announces Dosing of First Patient in First-in-Human Trial of RLY-2608 and Initiation of Expansion Cohorts for First-In-Human Trial of RLY-4008

author_avatar
NASDAQ Market News

SEngine Precision Medicine to Present Data Related to the Predictive Value of the PARIS® Test for Oncology Drugs Based on Retrospective Analysis at 2020 ASCO Annual Meeting

author_avatar
NASDAQ Market News